Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1

Glottic carcinoma is the most common laryngeal cancer. The outcomes for T1 bulky Glottic carcinoma and T2N0 Glottic carcinoma after radiation therapy alone are unsatisfactory. This study was conducted to evaluate the efficacy and safety of unique concurrent chemoradiotherapy regimen using S-1 for ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Takase, Yuuki, Itoh, Yoshiyuki, Ohtakara, Kazuhiro, Kawamura, Mariko, Ito, Junji, Oie, Yumi, Ono, Tamami, Sasaki, Yutaro, Nishida, Ayumi, Naganawa, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236680/
https://www.ncbi.nlm.nih.gov/pubmed/34239173
http://dx.doi.org/10.18999/nagjms.83.2.251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236680/
https://www.ncbi.nlm.nih.gov/pubmed/34239173
http://dx.doi.org/10.18999/nagjms.83.2.251

Ejemplares similares